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Summary
Despite numerous reports on MHC class II expression
by T cells from a wide spectrum of mammalian spe-
cies including humans, the biological relevance of
this phenomenon has never been tested with appro-
priately designed animal models. To address this is-
sue, we developed mouse models in which immature
thymocytes are the only positively selecting antigen-
presenting cells in the thymus. In these mice, CD4+ T
cells were generated with the appropriate maturation
phenotype and showed a diverse repertoire of TCR
Vs. The CD4+ T cells were functionally competent,
mediating effective allogeneic responses that in-
volved polyclonal TCR Vs. These results suggest
that the thymocyte-thymocyte (T-T) interaction oper-
ates as an independent pathway for CD4+ T cell selec-
tion in the thymi of species with MHC II-positive thy-
mocytes. This T-T interaction appears to be the basis
for the generation of donor MHC-restricted CD4+ T
cells in xenogeneic hosts.
Introduction
The fate of an immature thymocyte depends on the
type of antigen-presenting cell (APC) that it encounters.
Radiation-resistant cells of the thymus, which are pre-
sumably cortical thymic epithelial cells (cTECs), medi-
ate positive but not negative selection (Anderson et al.,
1994; Capone et al., 2001), whereas the reverse is the
case for hematopoietic-derived APCs, which are mainly
dendritic cells (DCs) (Blackman et al., 1990; Brocker et
al., 1997). Although this view is widely accepted, there
are reports that other types of cells are also capable
of inducing positive selection under defined conditions.*Correspondence: pshoe@plaza.snu.ac.kr
6 These authors contributed equally to this work.Intrathymic injection of transfected L cells (Pawlowski
et al., 1993), fibroblasts (Hugo et al., 1993), or medullary
epithelial-like cells (Vukmanovic et al., 1992) induces
the development of functional T cells that are restricted
to the MHC molecules present on the injected cells, but
absent from the thymic stroma. In vitro culture of mouse
embryonic stem cells with mouse bone marrow stromal
cell line OP9 expressing Delta-like I generated function-
ally competent CD8 T cells (Schmitt et al., 2004). The
evidence for hematopoietic cell contribution to positive
selection has been reported in a chimeric mouse sys-
tem (Bix and Raulet, 1992; Longo et al., 1985; Martinic
et al., 2003; Zinkernagel and Althage, 1999). Nude
(H-2b) mice reconstituted with an allogeneic thymus
plus bone marrow-derived cells (H-2k RAG−/−) could
mount both host and donor H-2-restricted cytotoxic
CD8 T cell activities (Zinkernagel and Althage, 1999),
while nude mice reconstituted with only allogeneic thy-
mus (H-2k RAG−/−) generated host H-2b-restricted ef-
fector T cells. In particular, tetraparental aggregation
chimeras from T cell- and B cell-deficient mice (H-2d
SCID or H-2b RAG−/−) and thymus-deficient nude mice
(H-2b or H-2d) have been used to show that selection
and/or MHC-dependent amplification and survival of a
mature T cell repertoire that is restricted to either thy-
mic or nonthymic epithelial MHC are equivalent (Marti-
nic et al., 2003). These exceptions suggest that the abil-
ity to select immature thymocytes is not limited to
TECs.
Previously, we reported that thymocytes themselves
represented another type of cell that might induce posi-
tive selection of human thymocytes during the fetal and
early postnatal periods (Park et al., 1992). These MHC
class II (MHC II)-expressing thymocytes were able to
select immature thymocytes under in vitro reaggrega-
tion culture conditions (Choi et al., 1997). MHC II mole-
cules have also been shown to be expressed on a pro-
portion of thymocytes and peripheral T cells in guinea
pigs (Burger et al., 1984), a large proportion of imma-
ture double-positive (DP) and mature single-positive
(SP) thymocytes in naive rats (Reizis et al., 1994), and
ovine peripheral T cells (Dutia et al., 1993). However,
the functional role of MHC II in T cells in vivo has not
yet been addressed using an appropriately designed
animal model. Thus, the fundamental differences in the
thymic expression patterns of MHC II between humans
and mice prompted us to develop mouse models that
mimic the human thymus setting.
In order to evaluate in depth the involvement of MHC
II-expressing thymocytes in the positive selection pro-
cess, we generated mice in which the transgenic hu-
man CIITA molecule, which is a master transcriptional
regulator of MHC II expression (Ting and Trowsdale,
2002), was expressed mostly in T-lineage cells under
the control of the proximal promoter of p56lck. In this
report, we demonstrate that MHC II-expressing thymo-
cytes mediate the selection of immature thymocytes
and that the T cells that mature after recognizing the
peptide/MHC complexes on thymocytes are functional,
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diverse Vβ usage.
Results
Generation of Transgenic Mice with MHC
II-Expressing Thymocytes
Since CIITA is a master regulator of the genes associ-
ated with MHC II expression and peptide presentation
(Chang et al., 1994), the expression levels of CIITA on
each subset of T cells in the lymphoid organs of the
transgenic mice could be evaluated indirectly by flow
cytometric analysis for MHC II. The transgenic mice of
line #1, which were designated as Plck-CIITATg, were
used for most of the subsequent studies as representa-
tive of five different founder lines. In these transgenic
mice, MHC class II (H2-Ab) was expressed on CD4+
CD8+ DP thymocytes, and expression persisted in the
mature CD4+ and CD8+ T cells of the spleen and lymph
nodes (Figure 1A), while all the different types of imma-
ture and mature T cells from wild-type littermates did
not show persistent expression of H2-Ab. The expres-
sion of H2-Ab on B cells and macrophages from the
spleens of Plck-CIITATg mice was not affected by Plck
promoter-driven CIITA transgene expression.
Selection of Single-Positive Thymocytes in CIITA
Transgenic Mice
We investigated whether MHC II-expressing thymo-
cytes mediated positive selection by analyzing the de-
velopmental profiles of thymic T cells from the Plck-
CIITATg mice. Compared with the wild-type controls, the
thymi of the Plck-CIITATg mice contained 1.5- to 2.7-
fold higher percentages and numbers of mature CD4
SP thymocytes (Figure 1B and Table 1). There was a
concomitant increase in the number of CD8+ SP cells
in the Plck-CIITATg thymi, probably due to the upregula-
tion of expression of MHC I on DP thymocytes by trans-
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tFigure 1. T-Lineage-Specific Induction of
MHC II Molecules and Enhanced Positive
Selection and Differentiation into SP Thymo-
cytes in CIITA Transgenic Mice
(A) Flow cytometric analysis of MHC II (H2-
Ab) expression on each subset of thymo-
cytes and splenocytes from transgenic (thick
line) or littermate controls (gray-filled thin
line). DP, double positive; SP, single positive;
T, CD3+ T cells; B, B220+ B cells; Mf, Mac-
1+ cells.
(B) Single-cell suspensions of thymocyte
and splenocytes were prepared from 6-week-
old Plck-CIITATg (Plck-CIITA) mice or litter-
mate normal (wt) mice and assessed for the
expression of CD4 and CD8 by surface stain-
ing and flow cytometry.
(C) The same CIITA cDNA fragment was
cloned into a cassette vector that contained
the CD2 promoter and used to generate CD2-
CIITATg mice. The thymocytes and spleno-
cytes from the CD2-CIITATg mice (CD2-CIITA)
and their normal littermates (wt) were pre-
pared and analyzed as described in (B). The
data shown in (B) and (C) are representative
of more than three independent experi-
ments.enic CIITA activity (see Figure S1A in the Supplemen-
al Data available with this article online; van den Elsen
nd Gobin, 1999). In the Plck-CIITATg mice, both the
D4+ and CD8+ SP thymocyte populations consisted
f cells that had recently undergone positive selection
nd differentiation, as evidenced by CD69 expression
nd the presence of terminally differentiated CD24low
ells (Figure S1A; Wenger et al., 1993).
To examine variations in T cell ontogeny in relation to
he promoter used, the same CIITA gene was linked to
he CD2 promoter (termed CD2-CIITATg), and the effect
n thymocyte maturation was compared with that of
lck-CIITATg mice. The degrees of differentiation into
D4+ and CD8+ SP cells (6.1% and 3.4%, respectively)
n the CD2-CIITATg thymi were intermediate between
hose in the Plck-CIITATg (8.0% and 5.7%, respectively)
nd wild-type (5.2% and 2.0%, respectively) thymi (Fig-
re 1C and Table 2), which reflects a correlation be-
ween the level of MHC molecules on DP thymocytes
one-fifth lower level on CD2-CIITATg than on Plck-
IITATg thymocytes; Figure S1B) and the degree of thy-
ic differentiation. The phenotypic features of the
plenocytes from these two types of transgenic mouse
ere basically identical to those of their normal litter-
ates, with minor exceptions, in that there were in-
reased percentages of T cells and concomitantly re-
uced B cell and macrophage populations (Figures
1C and S1D).
HC II-Positive Thymocytes Positively Select
hymocytes via T-T Interactions In Vivo
o address directly the question of whether MHC II-
ositive thymocytes mediate positive selection, Plck-
IITATg+CIITA0/0 mice, in which thymocytes act as the
nly thymic APCs, were produced by backcrossing
lck-CIITATg mice to CIITA-deficient (CIITA0/0) mice, and
hymic differentiation was evaluated. While differentia-
ion into CD4 SP cells was almost completely abro-
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389Table 1. T Cell Subpopulations of the Thymi and Spleens from Plck-CIITATg, Plck-CIITATg+CIITA0/0, and Littermate Mice
Thymus (×107) Spleen (×107)
Total CD4 SPa CD8 SPa Total CD4a CD8a
Experiment 1b
Wild-type 13.6 1.30 0.45 8.8 1.22 0.61
Plck-CIITATg 16.2 1.90 1.69 10.3 1.45 0.84
Plck-CIITATg+CIITA0/0 13.2 1.49 2.16 16.0 2.65 1.45
Experiment 2b
Wild-type 5.4 0.36 0.14 11.0 1.16 0.66
Plck-CIITATg 7.6 0.99 0.48 11.8 1.21 0.81
Plck-CIITATg+CIITA0/0 7.6 0.67 0.74 12.7 2.51 1.19
Experiment 3b
Wild-type 5.6 0.54 0.16 10.7 1.94 1.01
Plck-CIITATg 6.3 0.83 0.91 10.4 1.93 1.05
Plck-CIITATg+CIITA0/0 5.9 0.70 0.93 14.0 2.65 1.32
a Cell numbers were calculated by multiplying the total cell counts of thymocytes or splenocytes by the percentage of corresponding fractions
after flow cytometry.
b Each type of littermate obtained after backcrossing the Plck-CIITATg to CIITA0/0 mice was sacrificed at between 6 and 9 weeks of age.ited to T-lineage cells. CD4 T cell selection of the re-
Table 2. T Cell Subpopulations of the Thymi and Spleens from CD2-CIITATg and Littermate Mice
Thymus (×107) Spleen (×107)
Total CD4 SPa CD8 SPa Total CD4a CD8a
Wild-type 11.6 ± 0.9 0.62 ± 0.08 0.20 ± 0.06 8.5 ± 0.9 1.18 ± 0.28 0.89 ± 0.12
CD2-CIITATg 13.3 ± 3.8 0.90 ± 0.23 0.33 ± 0.12 8.9 ± 0.8 1.41 ± 0.11 0.76 ± 0.06
a Cell numbers were calculated by multiplying the total cell counts of thymocytes or splenocytes by the percentage of corresponding fractions
after flow cytometry (means + SD; three mice at 8 weeks of age per group).
ated H2-A -positive CD4 cells in the thymi and spleensgated by the lack of MHC II-expressing cells in the
thymi of the CIITA0/0 control mice (0.6%), a substantial
fraction of the thymocytes (7.4%) developed into CD4
SP cells in the Plck-CIITATg+CIITA0/0 mice (Figure 2A). A
time course study on the development of CD4+ T cells
showed that the overall developmental course of CD4+
T cells in the thymi of these Plck-CIITATg+CIITA0/0 mice
was similar to that of normal mice (Figure 2B). CD4+ T
cells developed in the thymi of all the different Plck-
CIITATg+CIITA0/0 mice that were generated by crossing
CIITA0/0 mice with different Plck-CIITATg founders (#1,
#16, and #11); the ratios of MHC II levels on DP thymo-
cytes to those on B cells (DP/B ratio) were 0.5, 0.13,
and 0.07 for #1, #16, and #11, respectively. The degrees
of CD4+ T cell selection correlated with the levels of
MHC II expression on DP thymocytes (Figure 2C). The
CD69 and CD24 expression profiles of the SP thymo-
cytes strongly suggest that the CD4 SP cells selected
in this way are phenotypically mature (Figure S2). More-
over, gating on terminally differentiated CD24low thymo-
cytes revealed that CD25+CD4+ regulatory T cells (Treg)
could be selected by MHC II expression on thymocytes
within the normal range, accounting for 5%–6% of ma-
ture CD4 SP cells (Figure 2D).
In addition to the tight control it exerts over MHC II
gene expression, CIITA has recently been postulated to
participate in CD4+ T-helper cell differentiation (Gourley
et al., 1999; Otten et al., 2003; Park et al., 2004). We
generated MHC class II-deficient mice (MHC II0/0) in
which the expression of the CIITA transgene was lim-
+sulting Plck-CIITATg+MHC II0/0 mice was then assessed
by flow cytometric analysis, based on the assumption
that if the CD4 SP cells observed in Plck-CIITATg+
CIITA0/0 mice (Figure 2A) were solely the result of CIITA
transgene expression, then the development of CD4 SP
thymocytes might occur even in the absence of MHC II
expression. However, MHC II null mice failed to gener-
ate CD4+ T cells, irrespective of whether they had the
Plck-CIITA transgene (Plck-CIITATg+MHC II0/0) or lacked
the Plck-CIITA transgene (MHC II0/0), unlike the MHC
II+/0 control (Figure 2E). These data confirm that the
differentiation of DP thymocytes into CD4 SP thymo-
cytes in the presence of Plck-CIITA transgene (Plck-
CIITATg+CIITA0/0) is not due to thymic differentiation in-
duced by the CIITA transgene itself.
It has been reported that residual MHC II is found on
a subset of cTECs in the thymi of CIITA0/0 mice (Chang
et al., 1996). This led us to suspect that CIITA-indepen-
dent MHC II molecules might be responsible for the se-
lection of the CD4 SP cells observed in Plck-CIITATg+
CIITA0/0 thymi. To verify the ability of MHC II-expressing
thymocytes to mediate positive selection, irradiation
BM chimeras were generated by injecting BM cells
from Plck-CIITATg mice into irradiated (800 cGy) MHC
II-deficient mice (Plck-CIITATg/MHC II0/0). The thymo-
cytes and splenocytes from the chimeras were ana-
lyzed for the generation of CD4+ cells 4 weeks and 6
weeks post-BMT, respectively. Maturation of the CD4+
T cells that were selected on MHC II-positive thymo-
cytes was confirmed by the presence of newly gener-
b +
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Immature Thymocytes
(A) Thymocytes and splenocytes were prepared from 6-week-old Plck-CIITATg+CIITA0/0 mice and stained with the anti-CD4 and anti-CD8 Abs.
The same analysis was performed in parallel on the thymocytes from CIITA-deficient (CIITA0/0) and heterozygous normal (CIITA+/0) littermates.
(B) Time course study on the CD4+ T cell development. Thymocytes and splenocytes from Plck-CIITATg+CIITA0/0 mice were prepared at 4, 8,
and 12 weeks of age and stained with the anti-CD4 and anti-CD8 Abs. The numbers of CD4 SP thymocytes and CD4+ T cells at the
corresponding ages are plotted and compared with those from age-matched CIITA+/0 littermates. Three mice per group were tested. Error
bars represent SD from the mean numbers.
(C) Thymocytes and splenocytes from different Plck-CIITATg+CIITA0/0 mouse lines (#1, #16, and #11) were prepared at 8 weeks of age. The
numbers (mean + SD) of CD4 SP thymocytes and CD4+ T cells are plotted. The MHC II levels on DP thymocytes from each founder are
denoted as relative to the levels on B cells (DP/B ratio).
(D) Thymocytes from Plck-CIITATg+CIITA0/0 were prepared at 4 weeks of age and stained with the anti-CD4, anti-CD24, and anti-CD25 Abs.
Terminally differentiated CD24low thymocytes were gated and the CD25+CD4+ T cells are boxed. The percentage of CD25+CD4+ T cells in the
CD24−CD4+ T cell population is noted.
(E) Thymocytes and splenocytes from 6-week-old Plck-CIITATg+MHC0/0 mice were analyzed for differentiation into CD4+ and CD8+ T cells.
The levels of differentiation of CD4+ and CD8+ T cells in the Plck-CIITATg+MHC0/0 mice are compared to those in control littermates with
(MHC+/0) or without (MHC0/0) MHC II expression. The dot plots show representative results for three different animals of each genotype.of the Plck-CIITATg/MHC II0/0 chimeras, while CD4+ T
cells were almost completely absent in the B6/MHC
II0/0 control chimeras, which received BM from normal
C57BL/6 (B6) mice (Figure 3A). Moreover, the presence
of a substantial population of H2-Ab-negative CD4+ T
cells in the spleens of the Plck-CIITATg/MHC II0/0 BM
chimeras implies that thymocytes that are derived not
only from donor Plck-CIITATg BM, but also from the re-
sidual host BM, are selected in the thymus, where posi-
tively selecting APCs are the only immature thymocytes
that originate from the Plck-CIITATg BM. The generation
of H2-Ab-negative CD4+ T cells in this chimera supports
the notion of positive selection of thymocytes via thy-
mocyte-thymocyte interactions.
Several studies have indicated that peptide/MHC
complexes on APCs can be transferred onto T cells via
tight conjugation between APCs and T cells (Hudrisier
and Bongrand, 2002; Undale et al., 2004). This raises
the possibility that TECs may acquire MHC II molecules
via physical contact with MHC II-positive thymocytes
and then select CD4+ T cells in the thymi of Plck-
CIITATg/MHC II0/0 chimeras. To determine whether the
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CECs in the thymi of Plck-CIITATg/MHC II0/0 chimeras
ad acquired MHC II molecules, the cells were stained
or MHC II and compared with other TECs from
6/MHC II0/0 chimeras and B6/B6 control chimeras
positive control). A minimal level of MHC II, which was
lmost identical to that on the TECs of B6/MHC II0/0
himeras, was detected on the chimeric TECs, in con-
rast to the high level of MHC II detected on the TECs
rom B6/B6 control chimeras (Figure 3B). We then at-
empted to detect in a functional manner the acquisi-
ion of MHC II by the TECs of Plck-CIITATg/MHC II0/0
himeras by flow cytometry using an in vitro stimulation
ssay with 5#-carboxyfluorescein diacetate succinimi-
yl ester (CFSE)-labeled B9 cells, which is a CD4+ T
ell clone that is specific for the H2-Ab-restricted male
inor histocompatibility antigen HY-Dby (Scott et al.,
000). As the presentation of HY-Dby/H2-Ab complexes
y male splenocytes drives B9 cell division, the pres-
nce/absence of the cognate peptide/MHC complexes
cquired by TECs was assessed by the proliferation of
ocultured B9 cells, which resulted in a reduction in
FSE intensity (Figure 3C). While a 5-day culture of the
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391Figure 3. CD4+ T Cells Are Selected by MHC II Ligands Provided by Immature Thymocytes
(A) Thymocytes and splenocytes were prepared from the BM chimeras (Plck-CIITATg/MHC II0/0) 4 weeks and 6 weeks after BMT, respectively.
The cells were stained with the anti-CD4-FITC and anti-CD8-APC mAbs and then compared with the cells from the control chimeras, WT
B6/MHC II0/0. The anti-H2-Ab-PE mAb was used to identify those lymphocytes that originated from the Plck-CIITATg BM.
(B) TECs were purified from the thymi of Plck-CIITATg/MHC II0/0 chimeras 4 weeks after BMT. Cells that were negative for CD11b, CD11c,
Thy1.2, CD3, CD4, and CD8 were gated as TECs, i.e., thymic stromal cells positive for CDR1, which is a marker for cortical thymic epithelial
cells (Small et al., 1989). The levels of MHC II on the TECs from Plck-CIITA/MHC II0/0 chimeras (solid line) were compared to those on the
cells purified from B6/MHC II0/0 chimeras (gray-filled dotted line) and B6/B6 chimeras (thin line).
(C) B9 cells labeled with CFSE were cultured with the TECs purified from Plck-CIITATg male/MHC II0/0 male, B6 male/MHC II0/0 male, and
B6 male/B6 male chimeras 4 weeks after BMT. For comparison, the CFSE-labeled B9 cells were cocultured with irradiated (2000 cGy)
splenocytes from B6 male or B6 female mice. Five days later, the cells from each culture were stained with anti-CD4-APC mAb and analyzed
for cell division by flow cytometry on CFSE dilution after gating on CD4-positive cells. The data shown in (B) and (C) are representative of
two independent experiments.
(D) The thymocytes and splenocytes from the mixed chimeras (Plck-CIITATg+B6.PL/MHC II0/0 and WT B6+B6.PL/MHC II0/0) were prepared
4 weeks and 8 weeks after BMT, respectively, and stained with anti-CD4-FITC and anti-CD8-APC mAbs. For the detection of CD4+ T cells
that originated from B6.PL, the cells were triple-stained with the anti-Thy1.1-PE, anti-Thy1.2-FITC, and anti-CD4-APC mAbs. The data shown
in (A) and (D) represent the results of three independent experiments with two animals per group.B9 cells with the TECs from B6 male/B6 male positive
control chimeras induced B9 cells to proliferate, B9
cells with TECs from the Plck-CIITATg/MHC II0/0 male
chimeras did not show any cell division, which was also
the case with the TECs from B6/MHC II0/0 male chi-
meras (Figure 3C). The failure to detect MHC II by anti-
body staining or by functional activation of the B9 clone
suggests that the contribution of TECs to thymic matu-
ration is negligible, as compared to that of MHC II-posi-
tive thymocytes in Plck-CIITATg/MHC II0/0 BM chi-
meras.
To demonstrate directly that immature thymocytes
receive the necessary signals for differentiation from
the TCR, rather than from MHC II expressed on thymo-
cytes, we produced irradiation mixed BM chimeras of
MHC II0/0 mice, into which mixed BM cells from Plck-
CIITATg (Thy1.2+) and B6.PL (Thy1.1+) mice were trans-
ferred (Plck-CIITATg+B6.PL/MHC II0/0). The develop-
ment of CD4+ T cells in the thymi and spleens of the
chimeras was examined 4 weeks and 8 weeks after en-
graftment, respectively, and the origins of the lympho-
cytes were assessed with the congeneic markers
Thy1.1 and Thy1.2. Control chimeras (B6+B6.PL/MHCII0/0), which were reconstituted with mixed BM from
normal B6 and B6.PL mice, were unable to produce
CD4+ T cells of either the B6.PL (Thy1.1) or B6 (Thy1.2)
BM origin. In contrast, CD4 SP thymocytes and mature
peripheral CD4+ T cells of both Thy1.2+ (Plck-CIITATg
donor and MHC II0/0 host) and Thy1.1+ (B6.PL donor)
BM origin were all generated in Plck-CIITATg+B6.PL/
MHC II0/0 chimeras, in which positively selecting MHC
II molecules were provided exclusively by immature
thymocytes of Plck-CIITATg BM origin (Figure 3D). It is
clear from the appropriate generation of Thy1.1+ CD4+
cells that the selection and differentiation of Thy1.1+
CD4+ T cells proceed via TCR recognition of MHC II
ligands provided by Thy1.2+ MHC II-expressing thymo-
cytes.
CD4+ T Cells Selected by Thymocytes Have Diverse
TCR Repertoires and Respond to Allogeneic
and Syngeneic Stimulation
To examine the TCR repertoire of the CD4+ T cells gen-
erated in the Plck-CIITATg+CIITA0/0 mice, CD4 SP thy-
mocytes and peripheral CD4+ T cells were typed for
TCR Vβ usage and compared to the corresponding
Immunity
392cells in Plck-CIITATg or normal mice. Although the per-
centages of each Vβ family in the CD4 SP thymocytes
and splenocytes showed marginal differences, the
overall Vβ profiles were similar for the three mouse
types, which indicates that MHC II-expressing thymo-
cytes are able to select CD4+ T cells with diverse Vβ
subsets (Figure 4).
The question as to whether CD4+ T cells selected on
MHC II-positive thymocytes are functionally competent
was addressed using mixed lymphocyte cultures in vitro.
The function of the CD4+ T cells from Plck-CIITATg+
CIITA0/0 mice was compared with those from Plck-
CIITATg and normal mice in mixed lymphocyte reac-
tions. CD4+ T cells from each mouse type were purified
and cultured with irradiated allogeneic (BALB/c) or syn-
geneic (B6) splenocytes as stimulators. The CD4+ T
cells from Plck-CIITATg+CIITA0/0 mice gave more vigor-
ous responses to allogeneic APCs than did those from
Plck-CIITATg or normal mice. Moreover, the CD4+ T cells
from Plck-CIITATg+CIITA0/0 mice showed proliferative
responses in the presence of syngeneic stimulator
cells, while the CD4+ T cells from CIITATg or wild-type
mice did not respond in this way (Figure 5A).
To confirm that the alloresponse observed with CD4+
T cells from Plck-CIITATg+CIITA0/0 mice was due to a
polyclonal T cell response, we typed the TCR Vβ ex-
pression of the responding CD4+ cells. The CD4+ T cells
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Spleens of Plck-CIITATg Mice and Plck-CIITATg+CIITA0/0 Mice
Thymocytes (top) and splenocytes (bottom) from normal B6 (wt),
Plck-CIITATg, and Plck-CIITATg+CIITA0/0 mice were triple-stained
with the anti-CD4-FITC and anti-CD8-APC mAbs, together with PE-
conjugated mAbs against various TCR Vβ chains. The percentages
of positive cells for each Vβ family were obtained after gating on
the CD4+ cells. The graphs show representative data for two ani-
mals of each type.
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A) The proliferative responses of CD4+ T cells from wild-type B6
wt), Plck-CIITATg, and Plck-CIITATg+CIITA0/0 mice were measured
n MLR cultures. The cultures were pulsed with [3H]-thymidine for
6 hr prior to harvest. Graph shows mean incorporation (+SD) of
hymidine in DNA measured in quadruplicate wells.
B) To analyze the TCR Vβ chain usage patterns of the CD4+ T cells
nvolved in alloresponses against BALB/c stimulators, splenocytes
rom wild-type B6 (wt), Plck-CIITATg, or Plck-CIITATg+CIITA0/0 mice
ere cultured with T cell-depleted BALB/c splenocytes for 2 days.
olchicine (1 M) was included in the cultures to prevent cell divi-
ion. The cells in the MLR cultures were triple-stained for CD4,
D69, and the indicated TCR Vβ chains. The percentages of Vβ
sage (means + SD; three mice per group) were calculated by gat-
ng on the CD4+CD69hi population.rom Plck-CIITATg+CIITA0/0 mice were cultured with T
ell-depleted BALB/c APCs in the presence of colchi-
ine, and the same culture was performed in parallel
sing CD4+ T cells from Plck-CIITATg or wild-type mice
s controls. Two days after initiation of the culture, the
CR usage of the BALB/c-reactive T cells was analyzed
y triple-staining the cells for CD69, CD4, and TCR Vβ.
ating on activated CD69hi cells revealed that the
ALB/c-reactive CD4+ T cells from the Plck-CIITATg+
IITA0/0 mice expressed multiple TCR Vβs at frequencies
imilar to those seen for CD4+ T cells from Plck-CIITATg
nd wild-type littermates (Figure 5B). These data sug-
est that the CD4+ T cells of Plck-CIITATg+CIITA0/0 mice
ave a polyclonal repertoire that is similar to that of
ormal B6 CD4+ T cells, at least in terms of response
o alloantigens.
iscussion
n this study, we present several lines of evidence re-
arding the ability of MHC II-positive immature thymo-
ytes to provide TCR stimulation that is adequate for
he initiation and completion of positive selection in vivo.
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393First, the increased CD4 SP populations in the thymi of
CIITA-transgenic mice (Plck-CIITATg and CD2-CIITATg),
in which MHC II is expressed both on immature thymo-
cytes and cTECs, correlated well with the level of MHC
II expression on the thymocytes, which was the case
for each of several founder lines. Second, CD4 SP thy-
mocytes and mature CD4+ T cells were still able to de-
velop in Plck-CIITATg mice on the CIITA0/0 background
(Plck-CIITATg+CIITA0/0), which suggests that the selec-
tion is limited to cortical thymocytes and produces
phenotypically mature CD4+ T cells. Third, there were
significant numbers of mature CD4+ T cells in the thymi
and peripheral lymphoid systems of Plck-CIITATg/
MHC II0/0 BM chimeras. Combined with the lack of MHC
II expression on TECs from the chimeras, this result indi-
cates that positive selection of thymocytes both in Plck-
CIITATg+CIITA0/0 mice and Plck-CIITATg/MHC II0/0 chi-
meras depends wholly on MHC II molecules expressed
exclusively on thymocytes.
The finding that the generation of CD4+ T cells was
completely abrogated in Plck-CIITATg+MHC II0/0 mice
serves as verification that the universal rule of MHC II
recognition by TCR for CD4+ T cell selection still oper-
ates, even in the presence of the CIITA transgene. In
particular, the selection of Thy1.1+ B6.PL-derived CD4+
T cells in the Plck-CIITATg+B6.PL/MHC II0/0 mixed chi-
meras clearly shows that Thy1.1+ immature thymocytes
operate their developmental program through signals
that emanate mainly from their TCRs via trans-recogni-
tion of MHC II, which is provided by Thy1.2+ Plck-
CIITATg thymocytes, rather than the MHC molecules
themselves.
CD4+ T cells that are selected exclusively on MHC II-
positive thymocytes (Plck-CIITATg+CIITA0/0) are func-
tional, as assayed by in vitro MLR with allogeneic and
syngeneic APCs. Since Treg cells could be selected in
the Plck-CIITATg+CIITA0/0 mice, the self-reactivity of the
CD4+ T cells may be due to the lack of MHC II expres-
sion on medullary epithelial cells and dendritic cells in
the CIITA0/0 background (lack of negative selection).
Self-reactivity of CD4+ T cells has also been reported
for K14 mice that express MHC II only on the thymic
cortical epithelium (Laufer et al., 1996, 1999). The fact
that the CD4+ T cells selected in Plck-CIITATg+CIITA0/0
mice showed self-reactivity suggests that thymocytes
are not involved in negative selection, despite contin-
ued expression of MHC II at the SP stage, probably due
to the lack of expression of costimulatory molecules
(such as B7) on their surfaces (data not shown).
In terms of the lack of B7 expression on the thymo-
cytes, our result that CD4+CD25+ Treg cells are gener-
ated (w5%–6% of mature CD4 SP thymocytes) in the
absence of B7 expression on the selecting cells in the
Plck-CIITATg+CIITA0/0 thymi is not coherent with the pre-
vious reports that B7-CD28 costimulation is required
for the generation and maintenance of Treg cells (Salo-
mon et al., 2000; Lohr et al., 2003; Tai et al., 2005). We
can provide only two possible explanations for this fea-
ture at the present. There seems to be a pathway that
is not strictly dependent on B7-CD28 costimulation for
the Treg cell development, as noted by the fact that
there remained a substantial number of functional Treg
cells in B7-deficient mice (Lohr et al., 2004). This path-
way would be taken particularly when Treg cells are se-lected by T-T interaction. The other possibility is based
on the fact that B7 expression on the other types of
cells is preserved in the Plck-CIITATg+CIITA0/0 thymi.
That is, signaling through B7-CD28 ligation could be
provided by T-DC and/or -TEC interaction simulta-
neously when TCR-MHC ligation is made by T-T inter-
action. The development of Treg cells could be induced
in this way.
The Vβ usage analysis of medullary and peripheral
CD4+ T cells, as well as the analysis of Vβ usage by
CD4+ T cells involved in alloresponses, suggest that the
gross repertoire is formed by positive selection in Plck-
CIITATg+CIITA0/0 mice. We have not been able to de-
monstrate that the Plck-CIITATg+CIITA0/0 mice have a
complete repertoire with respect to responsiveness to
a variety of antigens, since in vivo and in vitro antigen-
specific responses were obscured by the prominent
self-reactive responses. However, the CD4+ T cells from
Plck-CIITATg+CIITA0/0 mice gave consistently higher re-
sponses to allogeneic BALB/c APCs than did those
from wild-type littermates, which reflects a polyclonal
response to a spectrum of diverse peptides presented
by allogeneic MHC molecules (Surh et al., 1997). Thus,
the combination of broad-spectrum TCR Vβ usage and
strong responses to allogeneic MHC II molecules may
be an indirect indicator of the diversity of the CD4+ T
cells selected exclusively on MHC II-positive thymo-
cytes.
Considering the level of MHC II on human fetal DP
thymocytes (DP/B ratio of 0.12–0.13; data not shown),
the development of CD4+ T cells in the different Plck-
CIITATg+CIITA0/0 mouse lines in which the MHC II levels
on thymocytes are low (DP/B ratios of #16 and #11,
0.13–0.14 and 0.06–0.07, respectively) reflects the likeli-
hood of selection of CD4+ T cells by MHC II on DP thy-
mocytes in the human thymus. These data demonstrate
that thymocytes are able to select CD4+ T cells as long
as they express MHC II molecules, and the number of
selected CD4+ T cells correlates to some extent with
the level of MHC II on the thymocytes. Our data
strongly suggest that MHC II-expressing thymocytes
positively select CD4+ T cells in the thymus and that
this selection activity is not limited to cTECs. However,
in vitro culture of only MHC II-expressing DP thymo-
cytes does not support the development of DP thymo-
cytes into CD4+ T cells. Therefore, we cannot com-
pletely rule out a special role of cTECs in positive
selection; they provide some ancillary signals, such as
Notch, for thymocyte development and maturation in
the thymic environment (Anderson and Jenkinson,
2001; Anderson et al., 2001; Deftos et al., 2000).
Previously, we have argued that cognate interactions
between MHC II-positive immature thymocytes may
provide an additional mechanism for the extension of T
cell diversity (Choi et al., 2001). Currently, it is difficult
to determine the extent to which peptide diversity con-
tributes to these interactions between MHC II-positive
immature thymocytes and the magnitude of its influ-
ence on the shaping of the TCR repertoire. Further-
more, we do not know whether T-T interactions select
the same repertoire of T cells as that selected by thymic
cortical epithelial cells. The in vivo significance of this
issue remains a matter of speculation. We assume that
if another set of peptides (peptide fragments from the
Immunity
394TCRs themselves), a set that did not overlap with those
from TECs and DCs, could be presented by thymo-
cytes, this would contribute to the selection of a more
diverse TCR repertoire, potentially including “autoreac-
tive” T cells with specificity for isotypic or idiotypic
TCR determinants.
Our proposal of an independent selection pathway,
through which thymocytes positively select thymo-
cytes, has broad implications for the T cell biology of
humans, as well as for other mammalian species that
express MHC II molecules on their thymocytes. On this
basis, we believe that the T-T pathway provides an ex-
planation for the development and functional matura-
tion of human T cells in NOD/SCID/γnull mice (Hiramatsu
et al., 2003; Yahata et al., 2002) and Rag2−/− γc−/− mice
(Traggiai et al., 2004), into which human cord blood
CD34+ cells were transferred. The human CD4 T cells
generated in the xenogeneic mice were functionally
competent, able to mount response not only to mito-
genic stimuli, such as PHA and IL-2, but also to allogen-
eic human cells. These results indicated that the human
T cells developed in the mouse thymus had undergone
positive selection on human MHC. This notion was fur-
ther supported by the fact that reactivity to mouse DCs
was low, reflecting suboptimal xenogeneic cell interac-
tion. The authors of these papers were not able to pro-
vide any clear explanation for these results. Con-
sidering the natural expression of MHC II by human
immature thymocytes, the only positively selecting cells
presenting human MHC/peptide complexes in such xe-
nogeneic thymi would have to be MHC II-positive hu-
man thymocytes that originated from the injected
human CD34+ cells. This possibility of generation of
functional donor MHC-restricted CD4+ T cells remains
to be investigated.
Experimental Procedures
Mice
The cDNA fragment that encodes human CIITA was cloned into the
p1017 cassette, which contains the proximal p56lck promoter (kind
gift from Dr. Jae Kyun Shin, Sungkyunkwan University College of
Medicine, Suwon, Korea), and a cassette with the hCD2 promoter
(kind gift from Dr. Dimitris Kioussis, National Institute for Medical
Research, London, UK), for the generation of Plck-CIITATg mice and
CD2-CIITATg mice, respectively. Each transgenic DNA was microin-
jected into fertilized C57BL/6 (B6) oocytes. CIITA0/0 mice
(B6.129S2-C2tatm1Ccum/J), MHC II null mice (B6.129-H2dlAb1-Ea/J),
B6, and B6.PL mice were purchased from The Jackson Laboratory
(Bar Harbor, ME). All the mice were maintained under specific path-
ogen-free conditions at the animal facility at the Center for Animal
Resource Development, Seoul National University College of Medi-
cine, and were between 6 and 12 weeks of age when analyzed.
Experiments were performed after receiving approval of the Institu-
tional Animal Care and Use Committee of the Institute of Labora-
tory Animal Resources, Seoul National University.
Antibodies and Flow Cytometric Analysis
The following antibodies (Abs) were purchased from BD Phar-
mingen (San Diego, CA): APC-conjugated anti-CD3 (145-2C11),
anti-CD4 (GK1.5), and anti-CD8 (53-6.7); PE-conjugated anti-CD24
(M1/69), anti-CD69 (H1.2F3), anti-Thy1.1 (OX-7), anti-thy1.2 (30-
H12), anti-B220 (RA3-6B2), anti-H-2Kb (AF6-88.5), and anti-H2-Ab
(AF6-120.1); and FITC-conjugated anti-thy1.2 (30-H12) and anti-H2-
Ab (AF6-120.1). FITC-conjugated anti-CD11b (M1/70), anti-CD11c,
and anti-CD4 (GK1.5 or RM4-5) Abs and the PE-conjugated anti-
CD8 (53-6.7) Ab were purchased from DiNona (Seoul, Korea). The
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sntibodies against Vβ5.1&5.2 (MR9-4), Vβ11 (RR3-15), and Vβ13
R12-3) (kindly gifted by Dr. Phillipa Marrack, National Jewish
edical Research Center, Denver, CO) were conjugated with PE for
taining. Other PE-conjugated antibodies against Vβ2 (B20.6), Vβ3
KJ25), Vβ4 (KT4), Vβ6 (RR4-7), Vβ7 (TR310), Vβ8 (F23.1), and Vβ10
B21.5) were purchased from BD Pharmingen. Fresh cell suspen-
ions of thymocytes, splenocytes, and lymph node cells were
esuspended in FACS buffer (1× PBS with 0.1% BSA and 0.1%
odium azide). After staining with fluorescence-conjugated anti-
odies for 30 min at 4°C, the live cells, gated as the propidium
odide (PI; Sigma, St. Louis, MO)-negative population, were ana-
yzed using the FACSCalibur (Becton-Dickinson, Mountain View,
A) equipped with the CellQuest Pro software (Becton Dickinson,
an Jose, CA).
one Marrow Chimeras
HC II-deficient mice, 6–10 weeks of age, were irradiated with two
plit doses of 400 cGy from a 137Cs source with a 4 hr interval and
njected with BM 4 hr after the second irradiation. BM cells were
lushed from the femurs and tibiae of B6, Plck-CIITATg, or B6.PL
ice with PBS. A single-cell suspension of BM cells was filtered
hrough sterile nylon mesh, incubated with CD4 and CD8 magnetic
eads (Miltenyi Biotech, Auburn, CA), and subjected to MACS de-
letion according to manufacturer’s protocols (Miltenyi Biotech). T
ell-depleted BM cells (5 × 106) were prepared in a volume of 200
l PBS and injected intravenously into the lateral tail veins of the
rradiated recipient mice. At 4–8 weeks post-BMT, the mice were
acrificed for flow cytometric analysis of the thymocytes and
plenocytes of the chimeras.
urification of TECs and Staining for MHC II
he preparation of TECs has been described previously (Anderson
t al., 1993). In brief, 3–5 thymi from the bone marrow chimeras
ere pooled, minced, and treated with trypsin-DNase I. After incu-
ation with the biotinylated anti-CD45 mAb (Pharmingen) and sub-
equently with anti-biotin microbeads (Miltenyi Biotech), hemato-
oietic cells were depleted by MACS. The cells were then stained
ith FITC-conjugated the anti-H2-Ab mAb, a mixture of the PE-
onjugated anti-CD11b, CD11c, and Thy1.2 mAbs, and the APC-
onjugated anti-CD4, CD3, and CD8 mAbs. The TECs were gated
s cells that were negative for CD11b, CD11c, Thy1.2, CD3, CD4,
nd CD8.
FSE Labeling and Activation of B9 Cells
9 cells were maintained in culture by monthly restimulation with
rradiated (2000 cGy) splenocytes from B6 male mice. The B9 cells
n a resting state (4–5 weeks after restimulation) were resuspended
n 1× PBS and labeled with 20 M CFSE (Molecular Probes, Eu-
ene, OR). CFSE-labeled B9 cells (1 × 105) were cocultured with
-fold higher numbers of purified TECs in the wells of a round-
ottomed 96-well plate without IL-2 supplementation. After 5 days,
he cells were harvested, stained with anti-CD4-APC mAb, and
easured for the dilution of CFSE by flow cytometry after gating
n CD4-positive cells.
reparation of CD4+ T Cells and Mixed Lymphocyte Reactions
D4+ T cells from murine spleens and lymph nodes were purified
y magnetic cell sorting using MACS with anti-CD4 (GK1.5) micro-
eads. After determining the purity (95%–97%) of the collected
D4+ T cells by flow cytometry by use of the anti-CD4 mAb (RM4-5)-
ITC, the purified CD4+ T cells (1 × 105) were stimulated for 3 days
ith irradiated (2000 cGy) B6 or BALB/c splenocytes (1 × 105 or
× 105) in DMEM medium (GIBCO, Carlsbad, CA) that was supple-
ented with 10% FBS (HyClone, Logan, UT) and 50 M β-mercap-
oethanol. The cultures were pulsed with 1 Ci/well [3H]-thymidine
Amersham Bioscience) for the final 16 hr of incubation, and the
ean incorporation of thymidine in DNA was measured in quadru-
licate wells by liquid scintillation counting. To type the Vβ subsets
f the T cells involved in alloresponses, the CD4+ T cells (2.5 × 106)
rom Plck-CIITATg+CIITA0/0 mice were cultured with the same num-
er of T cell-depleted BALB/c APCs (irradiated at 2000 cGy) in the
resence of 1 M colchicine (Sigma) for 48 hr and then triple-
tained for CD4, CD69, and TCR Vβs (Surh et al., 1997). The CD4+
CD4 T Cell Selection via Central T-T Interaction
395T cells from the MLR were analyzed by flow cytometry for Vβ usage
after gating on CD4+CD69hi cells.
Supplemental Data
Supplemental Data include two figures and can be found with this
article online at http://www.immunity.com/cgi/content/full/23/4/
387/DC1/.
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